NKG2D-CAR-NK Cells Therapy(Changzhou No.2 People's Hospital)

N/A

Report date: 2024/04/24 20:00:35

Base Information

Drug NameNKG2D-CAR-NK Cells Therapy(Changzhou No.2 People's Hospital)
Drug Alias NameNKG2D Chimeric Antigen Receptor NK Cell Therapy(Changzhou No.2 People's Hospital)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionNatural killer cell replacementsNKG2D ligands modulators
TargetsNKG2D ligands
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChangzhou No.2 People’S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesChangzhou No.2 People’S Hospital
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A